Tokyo - Vision 2015

DAIICHI SANKYO Group has set the goal of "creating innovative pharmaceutical products on an ongoing basis and aiming to deploy businesses establishing the bases in major regions in the world” as a vision for 2015.

We aim to transfer DAIICHI SANKYO into a leading global pharmaceutical company that conducts business in the world’s major markets through its own operating bases, concentrates management resources into the pharmaceutical business and continuously creates and provides innovative pharmaceuticals.

Our numerical targets for 2015 are net sales of €12,5 billion* and an operating income margin of 25 per cent or more. In addition, 60 per cent of the company’s sales are planned to be realised outside of Japan. Thus, DAIICHI SANKYO will then be a truly international and globalised company.

This goal will be reached through own affiliates in the world’s major markets, by concentrating management resources on the pharmaceutical business, and by continuously creating and delivering innovative pharmaceuticalsto fullfil unmetmedical needs. Moreover, we are looking for attractive acquisition and in-licensing candidates on a product and company level.

The 2nd mid-term business management plan (detailing the strategy for the fiscal years 2010 to 2012) was announced on 12 March 2010.

More information can be found in the 2nd Mid-term Management Plan.


^{* Estimated exchange rate: ¥120=€1}